DOCSLIB.ORG

MUHC Publications

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MUHC Publications 2018 Publications Abrahamowicz, Michal M A Impact Abrahamowicz, Michal M A Factor Peer-Reviewed Articles, Case Reports, Clinical Trials Daniala L. Weir, Michal Abrahamowicz, Marie Eve Beauchamp, Dean T. Eurich. Acute vs cumulative benefits of metformin use in patients with type 2 diabetes and heart failure Diabetes, Obesity and Metabolism 20(11): 2653-2660, 2018 Peer-reviewed article Scopus ID: 85051047269 PubMed ID 29934961 Évelyne Vinet, Cristiano Soares de Moura, Christian A. Pineau, Michal Abrahamowicz, Jeffrey R. Curtis, Sasha R. Bernatsky. Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study Arthritis and Rheumatology 70(10): 1565-1571, 2018 Peer-reviewed article Scopus ID: 85052798241 PubMed ID Jenna Wong, Michal Abrahamowicz, David Llewellyn Buckeridge, Robyn M. Tamblyn. Derivation and validation of a multivariable model to predict when primary care physicians prescribe antidepressants for indications other than depression Clinical Epidemiology 10: 457-474, 2018 Peer-reviewed article Scopus ID: 85047738187 PubMed ID 3.8 Jenna Wong, Michal Abrahamowicz, David Llewellyn Buckeridge, Robyn M. Tamblyn. Assessing the accuracy of using diagnostic codes from administrative data to infer antidepressant treatment indications: a validation study Pharmacoepidemiology and Drug Safety 27(10): 1101-1111, 2018 Peer-reviewed article Scopus ID: 85045853046 PubMed ID 29687504 2.3 Marina Ámaral De Ávila Machado, Cristiano Soares De Moura, Steve Ferreira Guerra, Jeffrey R. Curtis, Michal Abrahamowicz, Sasha R. Bernatsky. Effectiveness and safety of tofacitinib in rheumatoid arthritis: A cohort study Arthritis Research and Therapy 20(1) , 2018 Peer-reviewed article Scopus ID: 85044268290 PubMed ID 29566769 Mary Ellen Kuenzig, Mohsen Sadatsafavi, Juan Antonio Aviña-Zubieta, Rebecca M. Burne, Michal Abrahamowicz, Marie Eve Beauchamp, Gilaad G. Kaplan, Eric I. Benchimol. Asthma is not associated with the need for surgery in crohn’s disease when controlling for smoking status: A population- based cohort study Clinical Epidemiology 10: 831-840, 2018 Peer-reviewed article Scopus ID: 85057734953 PubMed ID 3.8 Michal Abrahamowicz, John M. Esdaile, Rosalind Ramsey Goldman, Vibeke Strand, Peter L. Lipsky. Development and Validation of a Novel Evidence-Based Lupus Multivariable Outcome Score for Clinical Trials Arthritis and Rheumatology 70(9): 1450-1458, 2018 Peer-reviewed article Scopus ID: 85052532301 PubMed ID Michèle Bally, Marie Eve Beauchamp, Michal Abrahamowicz, Lyne Nadeau, James M. Brophy. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure Pharmacoepidemiology and Drug Safety 27(1): 69-77, 2018 Peer-reviewed article Scopus ID: 85039852067 PubMed ID 29171096 2.3 * Note: Publications for researchers with an asterisk are based on PubMed search only and have not been validated with the researchers. 20-Sep-19 Document produced by the Research Grants and Data Management Division of the Research Institute of MUHC Page 1 of 161 Abrahamowicz, Michal M A Miriam Marquis, Cyrielle Beaubois, Vincent Philippe Lavallée, Michal Abrahamowicz, Coraline Danieli, Sébastien Lemieux, Imran Ahmad, Andrew H. Wei, Stephen B. Ting, Shaun Fleming, Anthony P. Schwarer, David J. Grimwade, William Grey, Robert K. Hills, Pare High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia Blood Cancer Journal 8(8) , 2018 Peer-reviewed article Scopus ID: 85050732684 PubMed ID 30061630 8.1 Sarah Cohen, Aihua Liu, Michelle Z. Gurvitz, Liming Guo, Judith Therrien, Claudie Laprise, Jay Scott Kaufman, Michal Abrahamowicz, Ariane J. Marelli. Exposure to Low-Dose Ionizing Radiation from Cardiac Procedures and Malignancy Risk in Adults with Congenital Heart Disease Circulation 137(13): 1334-1345, 2018 Peer-reviewed article Scopus ID: 85048635270 PubMed ID 29269389 18.9 Thomas Rémen, Javier Pintos, Michal Abrahamowicz, Jack A. Siemiatycki. Risk of lung cancer in relation to various metrics of smoking history: A case-control study in Montreal 11 Medical and Health Sciences 1117 Public Health and Health Services BMC Cancer 18(1) , 2018 Peer-reviewed article Scopus ID: 85058891781 PubMed ID 30567516 3.3 Timothy J. Schmidt, Juan Antonio Aviña-Zubieta, Eric C. Sayre, Michal Abrahamowicz, John M. Esdaile, Diane V. Lacaille. Cardiovascular disease prevention in rheumatoid arthritis: Compliance with diabetes screening guidelines Journal of Rheumatology 45(10): 1367-1374, 2018 Peer-reviewed article Scopus ID: 85054101166 PubMed ID 30008457 3.5 Timothy J. Schmidt, Juan Antonio Aviña-Zubieta, Eric C. Sayre, Michal Abrahamowicz, John M. Esdaile, Diane V. Lacaille. Quality of care for cardiovascular disease prevention in rheumatoid arthritis: Compliance with hyperlipidemia screening guidelines Rheumatology (United Kingdom) 57(10): 1789-1794, 2018 Peer-reviewed article Scopus ID: 85054274334 PubMed ID 29955871 Vikki Ho, Coraline Danieli, Michal Abrahamowicz, Anne Sophie Bélanger, Vanessa Brunetti, Edgard E. Delvin, Julie Lacaille, Anita Koushik. Predicting serum Vitamin D concentrations based on self-reported lifestyle factors and personal attributes British Journal of Nutrition 120(7): 803-812, 2018 Peer-reviewed article Scopus ID: 85052710509 PubMed ID 3.7 Impact Afif, Waqqas Factor Peer-Reviewed Articles, Case Reports, Clinical Trials See: Bitton, Alain (Amine Benmassaoud et al). Scopus ID: 85038108116 PubMed ID 29243105 2.8 See: Bitton, Alain (Lóránt Gönczi et al). Scopus ID: 85032345900 PubMed ID 29107471 3.3 * Note: Publications for researchers with an asterisk are based on PubMed search only and have not been validated with the researchers. 20-Sep-19 Document produced by the Research Grants and Data Management Division of the Research Institute of MUHC Page 2 of 161 Afif, Waqqas See: Bitton, Alain (Sophie Restellini et al). Scopus ID: 85054214114 PubMed ID 29668893 4.3 See: Bitton, Alain (Talal Al-Taweel et al). Scopus ID: 85049600516 PubMed ID 29968143 2.8 Review Articles, Invited Publications Sophie Restellini, Reena Khanna, Waqqas Afif. Therapeutic drug monitoring with ustekinumab and vedolizumab in inflammatory bowel disease Inflammatory Bowel Diseases 24(10): 2165-2172, 2018 Review Scopus ID: 85056893675 PubMed ID 29788272 4.3 Impact Afilalo, Jonathan Factor Peer-Reviewed Articles, Case Reports, Clinical Trials Jonathan Afilalo, Abhinav Sharma, Shuaiqi Zhang, James Matthew Brennan, Fred H. Edwards, Michael J.M. MacK, James B. McClurken, Joseph C. Cleveland, Peter K.S. Smith, David Michael Shahian, Eric David Peterson, Karen P. Alexander. Gait speed and 1-year mortality following cardiac surgery: A landmark analysis from the society of thoracic surgeons adult cardiac surgery database Journal of the American Heart Association 7(23) , 2018 Peer-reviewed article Scopus ID: 85058455365 PubMed ID 30571598 4.5 Louis Mullie, Alexandrine Obrand, Melissa Bendayan, Amanda Trnkus, Marie Claude Ouimet, Emmanuel Moss, Annabel Angela Chen-Tournoux, Lawrence Glenn Rudski, Jonathan Afilalo. Phase angle as a biomarker for frailty and postoperative mortality: The BICS study Journal of the American Heart Association 7(17) , 2018 Peer-reviewed article Scopus ID: 85054549957 PubMed ID 30371163 4.5 Michael J. Goldfarb, Jonathan Afilalo, Alice Chan, Romana Herscovici, Bojan Cercek. Early mobility in frail and non-frail older adults admitted to the cardiovascular intensive care unit Journal of Critical Care 47: 9-14, 2018 Peer-reviewed article Scopus ID: 85048465923 PubMed ID 2.9 Olivier Beauchet, Shek H. Fung, Cyrille Patrice Launay, Jonathan Afilalo, Paul Herbert, Marc Afilalo, Julia Chabot. Predicting a long hospital stay after admission to a geriatric assessment unit: Results from an observational retrospective cohort study Maturitas 115: 110-114, 2018 Peer-reviewed article Scopus ID: 85049629809 PubMed ID 30049342 3.3 Sarah Blissett, Michael Chetrit, Bojan Kovacina, Vartan Mardigyan, Jonathan Afilalo. Performing Cardiac Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices: A Contemporary Review Canadian Journal of Cardiology 34(12): 1682-1686, 2018 Peer-reviewed article Scopus ID: 85057571827 PubMed ID 30527159 4.5 See: Cantarovich, Marcelo (Lior Bibas et al). Scopus ID: 85056803618 PubMed ID 29877924 4.0 * Note: Publications for researchers with an asterisk are based on PubMed search only and have not been validated with the researchers. 20-Sep-19 Document produced by the Research Grants and Data Management Division of the Research Institute of MUHC Page 3 of 161 Afilalo, Jonathan See: Huynh, Thao (Étienne L. Couture et al). Scopus ID: 85054179409 PubMed ID 30269415 2.6 See: Martucci, Giuseppe (Laura M. Drudi et al). Scopus ID: 85055112621 PubMed ID 30343019 See: Martucci, Giuseppe (Laura M. Drudi et al). Scopus ID: 85045944139 PubMed ID 29344620 10.1 Review Articles, Invited Publications See: Martucci, Giuseppe (Michele Pighi et al). Scopus ID: 85051276775 PubMed ID Impact Ahmad Khan, Faiz Factor Peer-Reviewed Articles, Case Reports, Clinical Trials Ann C. Miller, Viktoriya Livchits, Faiz Ahmad Ahmad Khan, Sidney S. Atwood, Sergei Kornienko, Yulia Kononenko, Irina А. Vasilyeva, Salmaan A. Keshavjee. Turning Off the Tap: Using the FAST Approach to Stop the Spread of Drug-Resistant Tuberculosis in the Russian Federation Journal of Infectious Diseases 218(4): 654-658, 2018 Peer-reviewed article Scopus ID: 85050036076 PubMed ID 5.2 Joel Philip Samuels, Aashna Sood, Jonathon R. Campbell, Faiz Ahmad Ahmad Khan, James Cameron Johnston.
Load more

Recommended publications
  • 5Th Southeastern Mycobacteria Meeting
    5th Southeastern Mycobacteria Meeting January 24-26, 2014 University of Alabama at Birmingham Heritage Hall & Edge of Chaos, Lister Hill Library University Blvd, Birmingham, AL Keynote Speaker: Lalita Ramakrishnan, M.B.B.S, Ph.D. University of Washington, Seattle, WA Organizing Committee: Michael Niederweis, Ph.D. University of Alabama at Birmingham Miriam Braunstein, Ph.D. University of North Carolina, Chapel Hill Jyothi Rengarajan, Ph.D. Emory University, Atlanta Frank Wolschendorf, Ph.D. University of Alabama at Birmingham 5th Southeastern Mycobacteria Meeting – Program 2 Meeting Program Friday, January 24, 2014 6:30 – 9:30 p.m. Welcome reception and meeting registration Edge of Chaos, 4th floor of Lister Hill Library 1700 University Blvd, Birmingham, AL Saturday, January 25, 2014 8:00 a.m. – 12:00 p.m. Oral presentations Heritage Hall, 1401 University Blvd 12:00 p.m. – 1:45 p.m. Lunch and poster session I Edge of Chaos, 4th floor of Lister Hill Library 2:00 p.m. – 3:35 p.m. Oral presentations Heritage Hall 3:35 p.m. – 4:25 p.m. Keynote Address: Lalita Ramakrishnan Heritage Hall 4:30 p.m. – 6:15 p.m. Poster session II Edge of Chaos, 4th floor of Lister Hill Library 7:00 p.m. – 11:00 p.m. Dinner and entertainment Iron City Grill, 513 22nd St. S, Birmingham, AL Sunday, January 26, 2014 9:00 a.m. – 11:25 a.m. Oral presentations Heritage Hall 11:30 a.m. – 12:00 p.m. Awards and prizes Heritage Hall 12:00 p.m. – 1:00 p.m. Lunch Heritage Hall 5th Southeastern Mycobacteria Meeting – Program 3 Detailed Meeting Schedule Friday, January 24, 2014 6:30 – 9:30 p.m.
    [Show full text]
  • Pleiotropic Effects for Parkin and LRRK2 in Leprosy Type-1 Reactions and Parkinson’S Disease
    Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s disease Vinicius M. Favaa,b,1,2, Yong Zhong Xua,b, Guillaume Lettrec,d, Nguyen Van Thuce, Marianna Orlovaa,b, Vu Hong Thaie, Shao Taof,g, Nathalie Croteauh, Mohamed A. Eldeebi, Emma J. MacDougalli, Geison Cambrij, Ramanuj Lahirik, Linda Adamsk, Edward A. Foni, Jean-François Trempeh, Aurélie Cobatl,m, Alexandre Alcaïsl,m, Laurent Abell,m,n, and Erwin Schurra,b,o,1,2 aProgram in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada H4A3J1; bMcGill International TB Centre, Montreal, QC, Canada H4A 3J1; cMontreal Heart Institute, Montreal, QC, Canada H1T 1C8; dDepartment of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada H3T 1J4; eHospital for Dermato-Venereology, District 3, Ho Chi Minh City, Vietnam; fDivision of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada H3G 2M1; gThe Translational Research in Respiratory Diseases Program, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada H4A 3J1; hCentre for Structural Biology, Department of Pharmacology & Therapeutics, McGill University, Montreal, QC, Canada H3G 1Y6; iMcGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4; jGraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, PR, 80215-901, Brazil; kNational Hansen’s Disease Program, Health Resources and Services Administration, Baton Rouge, LA 70803; lLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale 1163, 75015 Paris, France; mImagine Institute, Paris Descartes-Sorbonne Paris Cité University, 75015 Paris, France; nSt.
    [Show full text]
  • Moderated by Adaptive Immunity Granulomatous Tuberculosis and Is
    Mycobacterium marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity Laura E. Swaim, Lynn E. Connolly, Hannah E. Volkman, Olivier Humbert, Donald E. Born and Lalita Ramakrishnan Infect. Immun. 2006, 74(11):6108. DOI: 10.1128/IAI.00887-06. Downloaded from Updated information and services can be found at: http://iai.asm.org/content/74/11/6108 http://iai.asm.org/ These include: SUPPLEMENTAL MATERIAL http://iai.asm.org/content/suppl/2006/10/12/74.11.6108.DC1.ht ml REFERENCES This article cites 52 articles, 16 of which can be accessed free at: http://iai.asm.org/content/74/11/6108#ref-list-1 on June 26, 2012 by University of Washington CONTENT ALERTS Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more» CORRECTIONS An erratum has been published regarding this article. To view this page, please click here Information about commercial reprint orders: http://journals.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ INFECTION AND IMMUNITY, Nov. 2006, p. 6108–6117 Vol. 74, No. 11 0019-9567/06/$08.00ϩ0 doi:10.1128/IAI.00887-06 Copyright © 2006, American Society for Microbiology. All Rights Reserved. Mycobacterium marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity† Laura E. Swaim,1‡ Lynn E. Connolly,2‡* Hannah E. Volkman,3 Olivier Humbert,1§ Donald E. Born,4 and Lalita Ramakrishnan1,2,5 Departments of Microbiology,1 Medicine,2 Immunology,5 and Pathology4 and Molecular and Cellular Biology Graduate Program,3 University of Washington, Seattle, Washington 98195 Received 5 June 2006/Returned for modification 6 July 2006/Accepted 31 July 2006 Downloaded from The zebrafish, a genetically tractable model vertebrate, is naturally susceptible to tuberculosis caused by Mycobacterium marinum, a close genetic relative of the causative agent of human tuberculosis, Mycobacterium tuberculosis.
    [Show full text]
  • Ed 376 019 Title Institution Pub Date Note Available From
    DOCUMENT RESUME ED 376 019 SE 053 531 TITLE Grants for Science Education, 1992-1993. INSTITUTION Howard Hughes Medical Inst., Chevy Chase, MD. Office of Grants and Special Programs. PUB DATE 93 NOTE 141p. AVAILABLE FROMHoward Hughes Medical Institute, Office of Grants and Special Programs, 4000 Jones Bridge Road, Chevy Chase, MD 20815-6789. PUB TYPE Guides Non-Classroom Use (055) EDRS PRICE MF01/PC06 Plus Postage. DESCRIPTORS *Biomedicine; *Grants; Higher Education; *Research; *Science Education; Secondary Education ABSTRACT To help strengthen education in medicine, biology, and related sciences, the Howard Hughes Medical Institute (HHMI) launched a grants program in these areas in 1987. The grants support graduate, undergraduate, precollege and public science education, and fundamental biomedical research abroad. This document provides summaries of all projects receiving grants in 1992 and is also, in effect, a 1992 annual report for each Programmatic Area supported by HHMI. (ZWH) *********************************************************************** * Reproductions supplied by EDRS are the best that can be made from the original document. *********************************************************************** 9- -.I I, .10 It vr .. * ie Ar -4",_ -7 \---(_,- 1 a Si It I 1 a a I tIt "PERMISSION TO REPRODUCETHIS U S DEPARTMENT OF EDUCATION GRANTED BY Orrice of Educahona, Research and irnomvernent MATERIAL HAS BEEN EDUCATIONAL RESOURCES INFORMATION CENTER (EPICI U ER-P,C This document has been reproduced as owed Iron the person or Organitation originating it C.1 Minor changes name been made to improve reproduction quality TO THE EDUCATIONALRESOURCES Ponis of vev, o ot),n(Ons staled .nlh'S doc 0 meal do not necessarily represent othc,a1 INFORMATION CENTER (ERIC) OE RI pc on or policy I I I a I -SET COPYAWAt'tMI 2 Copyright ©1993 by the Howard Hughes Medical Institute Office of Grants and Special Programs.
    [Show full text]
  • Lalita Ramakrishnan, Phd Microbiologist
    Career Interview 3 Name_______________________________Date_____________Period_________ Lalita Ramakrishnan, PhD Microbiologist 1. Where did you grow up? I grew up in a small town in India called Baroda. The name of the town has now changed to its Pre-British name, Vadodara, which means City of the Banyon Tree. 2. What do you do (i.e. what career or field are you in, what is the title of your position)? I am a Professor of Microbiology and Medicine at the University of Washington. Mostly I do research in tuberculosis, train students and Postdoctoral Fellows (which are people with a PhD who are looking for further training). I also spend a small part of my time as an infectious disease doctor. 3. How did you choose your career? When did you first know this is the career you wanted? No, I wouldn’t say that I always knew that I wanted to do this. When I grew up in India, I was a pretty good student, but I wasn’t particularly good at one thing versus another, so the default in my community was to go to medical school. This was based on your class rank order in school, not like here in America where you have to do lots of stuff specifically to get in to medical school. But I was unhappy in medical school. I was unhappy seeing all of the disease and poverty, and lots of rote learning, which is what medical school in India was like back then. I decided to get a PhD after medical school, so I got a scholarship for a PhD program here in America, in Immunology.
    [Show full text]
  • Hif-1Α-Induced Expression of Il-1Β Protects Against Mycobacterial Infection in Zebrafish
    This is a repository copy of Hif-1α-Induced Expression of Il-1β Protects against Mycobacterial Infection in Zebrafish.. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/140233/ Version: Published Version Article: Ogryzko, N.V. orcid.org/0000-0003-0199-5567, Lewis, A. orcid.org/0000-0002-1156-3592, Wilson, H.L. orcid.org/0000-0002-7892-3425 et al. (3 more authors) (2019) Hif-1α-Induced Expression of Il-1β Protects against Mycobacterial Infection in Zebrafish. Journal of Immunology, 202 (2). pp. 494-502. ISSN 0022-1767 https://doi.org/10.4049/jimmunol.1801139 Reuse This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the authors for the original work. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Hif-1α−Induced Expression of Il-1β Protects against Mycobacterial Infection in Zebrafish Nikolay V. Ogryzko, Amy Lewis, Heather L. Wilson, Annemarie H. Meijer, Stephen A. Renshaw and Philip M. This information is current as Elks of March 18, 2019. J Immunol 2019; 202:494-502; Prepublished online 14 December 2018; doi: 10.4049/jimmunol.1801139 http://www.jimmunol.org/content/202/2/494 Downloaded from by guest on March 18, 2019 Supplementary http://www.jimmunol.org/content/suppl/2018/12/14/jimmunol.180113 Material 9.DCSupplemental References This article cites 50 articles, 17 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/202/2/494.full#ref-list-1 Why The JI? Submit online.
    [Show full text]
  • Potentiation of P2RX7 As a Host-Directed Strategy for Control Of
    RESEARCH ARTICLE Potentiation of P2RX7 as a host-directed strategy for control of mycobacterial infection Molly A Matty1,2, Daphne R Knudsen1, Eric M Walton1, Rebecca W Beerman1, Mark R Cronan1, Charlie J Pyle1, Rafael E Hernandez3,4, David M Tobin1,5* 1Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, United States; 2University Program in Genetics and Genomics, Duke University, Durham, United States; 3Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, United States; 4Department of Pediatrics, University of Washington, Seattle, United States; 5Department of Immunology, Duke University School of Medicine, Durham, United States Abstract Mycobacterium tuberculosis is the leading worldwide cause of death due to a single infectious agent. Existing anti-tuberculous therapies require long treatments and are complicated by multi-drug-resistant strains. Host-directed therapies have been proposed as an orthogonal approach, but few have moved into clinical trials. Here, we use the zebrafish-Mycobacterium marinum infection model as a whole-animal screening platform to identify FDA-approved, host- directed compounds. We identify multiple compounds that modulate host immunity to limit mycobacterial disease, including the inexpensive, safe, and widely used drug clemastine. We find that clemastine alters macrophage calcium transients through potentiation of the purinergic receptor P2RX7. Host-directed drug activity in zebrafish larvae depends on both P2RX7 and inflammasome signaling. Thus, targeted activation of a P2RX7 axis provides a novel strategy for enhanced control of mycobacterial infections. Using a novel explant model, we find that clemastine is also effective within the complex granulomas that are the hallmark of mycobacterial infection.
    [Show full text]
  • Spreading of a Mycobacterial Cell Surface Lipid Into Host Epithelial Membranes Promotes 2 Infectivity 3 4 C.J
    bioRxiv preprint doi: https://doi.org/10.1101/845081; this version posted June 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Spreading of a mycobacterial cell surface lipid into host epithelial membranes promotes 2 infectivity 3 4 C.J. Cambier1, Steven M. Banik1, Joseph A. Buonomo1, and Carolyn R. Bertozzi1,2,* 5 6 1Department of Chemistry, Stanford University, Stanford, CA, 94305, USA 7 2Howard Hughes Medical Institute, Stanford University, Stanford, CA, 94305, USA 8 *Correspondence: [email protected] 9 10 ABSTRACT 11 Several virulence lipids populate the outer cell wall of pathogenic mycobacteria (Jackson, 12 2014). Phthiocerol dimycocerosate (PDIM), one of the most abundant outer membrane lipids 13 (Anderson, 1929), plays important roles in both defending against host antimicrobial programs 14 (Camacho et al., 2001; Cox et al., 1999; Murry et al., 2009) and in evading these programs 15 altogether (Cambier et al., 2014a; Rousseau et al., 2004). Immediately following infection, 16 mycobacteria rely on PDIM to evade toll-like receptor (TLR)-dependent recruitment of 17 bactericidal monocytes which can clear infection (Cambier et al., 2014b). To circumvent the 18 limitations in using genetics to understand virulence lipid function, we developed a chemical 19 approach to introduce a clickable, semi-synthetic PDIM onto the cell wall of Mycobacterium 20 marinum. Upon infection of zebrafish, we found that PDIM rapidly spreads into host epithelial 21 membranes, and that this spreading inhibits TLR activation.
    [Show full text]
  • Scoping Report on Hospital and Health Care Acquisition of COVID-19 and Its Control This Paper Has Drawn on Evidence Available up to 28 June 2020
    Scoping Report on Hospital and Health Care Acquisition of COVID-19 and its Control This paper has drawn on evidence available up to 28 June 2020. Further evidence on this topic is constantly published and DELVE may return to this topic in the future. This independent overview of the science has been provided in good faith by subject experts. DELVE and the Royal Society accept no legal liability for decisions made based on this evidence. DELVE DELVE: Data Evaluation and Learning for Viral Epidemics is a multi-disciplinary group, convened by the Royal Society, to support a data-driven approach to learning from the different approaches countries are taking to managing the pandemic. This effort has been discussed with and welcomed by Government, who have arranged for it to provide input through SAGE, its scientific advisory group for emergencies. DELVE contributed data driven analysis to complement the evidence base informing the UK’s strategic response, by: — Analysing national and international data to determine the effect of different measures and strategies on a range of public health, social and economic outcomes — Using emerging sources of data as new evidence from the unfolding pandemic comes to light — Ensuring that the work of this group is coordinated with others and communicated as necessary both nationally and internationally Citation The DELVE Initiative (2020), Scoping Report on Hospital and Health Care Acquisition of COVID-19 and its Control. DELVE Report No. 3. Published 06 July 2020. Available from https://rs-delve.github.io/reports/2020/07/06/nosocomial-scoping-report.html.
    [Show full text]
  • Host Evasion and Exploitation Schemes of Mycobacterium Tuberculosis
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Leading Edge Review Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis C.J. Cambier,1 Stanley Falkow,2 and Lalita Ramakrishnan1,3,* 1University of Washington, Seattle, WA 98195, USA 2Stanford University, Stanford, CA 94305, USA 3University of Cambridge, Cambridge CB2 1TN, UK *Correspondence: [email protected] http://dx.doi.org/10.1016/j.cell.2014.11.024 Tuberculosis, an ancient disease of mankind, remains one of the major infectious causes of human death. We examine newly discovered facets of tuberculosis pathogenesis and explore the evolution of its causative organism Mycobacterium tuberculosis from soil dweller to human pathogen. M. tuberculosis has coevolved with the human host to evade and exploit host macrophages and other immune cells in multiple ways. Though the host can often clear infection, the organism can cause transmissible disease in enough individuals to sustain itself. Tuberculosis is a near-perfect paradigm of a host-pathogen relationship, and that may be the challenge to the development of new therapies for its eradication. Introduction in the right host, run amok to cause a disease that is of question- Tuberculosis (TB) has afflicted humans for about 70,000 years able benefit to the pathogens’ evolutionary survival. These and continues to take a huge toll on human life and health, factors probably give the microbe a selective colonization with 8.6 and 1.3 million cases and deaths, respectively, in 2013 advantage on mucosal surfaces, where bacterial competition is (Zumla et al., 2013; Comas et al., 2013).
    [Show full text]
  • Acknowledgment of Reviewers, 2009
    Proceedings of the National Academy ofPNAS Sciences of the United States of America www.pnas.org Acknowledgment of Reviewers, 2009 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2009. Their generous contribution is deeply appreciated. A R. Alison Adcock Schahram Akbarian Paul Allen Lauren Ancel Meyers Duur Aanen Lia Addadi Brian Akerley Phillip Allen Robin Anders Lucien Aarden John Adelman Joshua Akey Fred Allendorf Jens Andersen Ruben Abagayan Zach Adelman Anna Akhmanova Robert Aller Olaf Andersen Alejandro Aballay Sarah Ades Eduard Akhunov Thorsten Allers Richard Andersen Cory Abate-Shen Stuart B. Adler Huda Akil Stefano Allesina Robert Andersen Abul Abbas Ralph Adolphs Shizuo Akira Richard Alley Adam Anderson Jonathan Abbatt Markus Aebi Gustav Akk Mark Alliegro Daniel Anderson Patrick Abbot Ueli Aebi Mikael Akke David Allison David Anderson Geoffrey Abbott Peter Aerts Armen Akopian Jeremy Allison Deborah Anderson L. Abbott Markus Affolter David Alais John Allman Gary Anderson Larry Abbott Pavel Afonine Eric Alani Laura Almasy James Anderson Akio Abe Jeffrey Agar Balbino Alarcon Osborne Almeida John Anderson Stephen Abedon Bharat Aggarwal McEwan Alastair Grac¸a Almeida-Porada Kathryn Anderson Steffen Abel John Aggleton Mikko Alava Genevieve Almouzni Mark Anderson Eugene Agichtein Christopher Albanese Emad Alnemri Richard Anderson Ted Abel Xabier Agirrezabala Birgit Alber Costica Aloman Robert P. Anderson Asa Abeliovich Ariel Agmon Tom Alber Jose´ Alonso Timothy Anderson Birgit Abler Noe¨l Agne`s Mark Albers Carlos Alonso-Alvarez Inger Andersson Robert Abraham Vladimir Agranovich Matthew Albert Suzanne Alonzo Tommy Andersson Wickliffe Abraham Anurag Agrawal Kurt Albertine Carlos Alos-Ferrer Masami Ando Charles Abrams Arun Agrawal Susan Alberts Seth Alper Tadashi Andoh Peter Abrams Rajendra Agrawal Adriana Albini Margaret Altemus Jose Andrade, Jr.
    [Show full text]
  • Validation of Animal Models and Tools for Biomedical Research Session II
    U.S. Department of Health and Human Services National Institutes of Health Division of Program Coordination, Planning, and Strategic Initiatives Office of Research Infrastructure Programs Division of Comparative Medicine Validation of Animal Models and Tools for Biomedical Research Session II. Validation of Zebrafish Models for Preclinical Research Tuesday, November 24, 2020 Virtual Meeting Workshop Report Table of Contents Executive Summary ....................................................................................................................................... i Workshop Report .......................................................................................................................................... 1 Opening Remarks ...................................................................................................................................... 1 Zebrafish Models of Neurological Disease ............................................................................................... 1 Zebrafish Models of Genetic Epilepsies: Challenges and Opportunities ................................................. 2 Zebrafish Models Validate Undiagnosed Human Diseases ...................................................................... 2 Forward and Reverse Genetic Approaches in Zebrafish to Understanding Scoliosis .............................. 3 Cellular Barcoding in Zebrafish Models of Disease................................................................................. 3 Zebrafish as Models for Infectious
    [Show full text]